Trade Bioventus Inc. - BVS CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.09 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023512% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.00129% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 9.91 |
| Open | 9.84 |
| 1-Year Change | 117.7% |
| Day's Range | 9.84 - 10.16 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Feb 21, 2025 | 9.96 | 0.12 | 1.22% | 9.84 | 10.21 | 9.72 |
| Feb 20, 2025 | 9.91 | -0.23 | -2.27% | 10.14 | 10.20 | 9.70 |
| Feb 19, 2025 | 10.27 | 0.11 | 1.08% | 10.16 | 10.53 | 10.16 |
| Feb 18, 2025 | 10.34 | 0.02 | 0.19% | 10.32 | 10.57 | 10.11 |
| Feb 14, 2025 | 10.36 | -0.08 | -0.77% | 10.44 | 10.44 | 10.24 |
| Feb 13, 2025 | 10.37 | 0.07 | 0.68% | 10.30 | 10.40 | 10.10 |
| Feb 12, 2025 | 10.22 | -0.23 | -2.20% | 10.45 | 10.55 | 10.11 |
| Feb 11, 2025 | 10.65 | 0.16 | 1.53% | 10.49 | 10.69 | 10.47 |
| Feb 10, 2025 | 10.68 | 0.26 | 2.50% | 10.42 | 10.74 | 10.42 |
| Feb 7, 2025 | 10.50 | -0.23 | -2.14% | 10.73 | 10.80 | 10.23 |
| Feb 6, 2025 | 10.81 | -0.22 | -1.99% | 11.03 | 11.05 | 10.76 |
| Feb 5, 2025 | 11.02 | 0.10 | 0.92% | 10.92 | 11.11 | 10.88 |
| Feb 4, 2025 | 10.94 | 0.75 | 7.36% | 10.19 | 10.94 | 10.19 |
| Feb 3, 2025 | 10.46 | 0.28 | 2.75% | 10.18 | 10.71 | 10.18 |
| Jan 31, 2025 | 10.65 | 0.14 | 1.33% | 10.51 | 10.77 | 10.48 |
| Jan 30, 2025 | 10.61 | 0.11 | 1.05% | 10.50 | 10.75 | 10.45 |
| Jan 29, 2025 | 10.45 | 0.19 | 1.85% | 10.26 | 10.53 | 10.23 |
| Jan 28, 2025 | 10.37 | 0.44 | 4.43% | 9.93 | 10.37 | 9.93 |
| Jan 27, 2025 | 10.01 | 0.19 | 1.93% | 9.82 | 10.03 | 9.77 |
| Jan 24, 2025 | 9.99 | 0.17 | 1.73% | 9.82 | 10.12 | 9.82 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Bioventus Inc. Company profile
About Bioventus Inc
Bioventus Inc is a global medical device company. The Company is focused on developing and commercializing clinically and minimally invasive treatments that engage and enhance the body’s natural healing process. The Company’s portfolio of products includes OA joint pain treatment and joint preservation, bone graft substitutes and minimally invasive fracture treatment. The OA joint pain treatment and joint preservation is focused on orthopedics. Its bone graft substitutes (BGSs) offers portfolio of products including human tissue allografts and synthetics. Its BGS products can be used in conjunction with any orthopedic fixation and spinal fusion implant. They are designed to improve bone fusion rates following spinal fusion and other orthopedic surgeries and reduce the need for using the patient’s own bone.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Bioventus Inc revenues increased 34% to $430.9M. Net income applicable to common stockholders increased from $4.4M to $19.4M. Revenues reflect U.S. segment increase of 32% to $387.6M, International segment increase of 58% to $43.3M. Net income benefited from Stock-based Compensation in SGA decrease from $10.1M (expense) to $4.5M (income), Foreign Exchange Gain/Loss increase of 13% to $132K (income).
| Industry: | Medical Equipment |
4721 Emperor Boulevard, Suite 100
DURHAM
NORTH CAROLINA 27703
US
News
Microsoft Stock Price Forecast for 2025 and beyond: Third party price target
We assess the likely level of the Microsoft stock price in 5 years, and possible drivers behind the stock’s past performance. Read on...
18:29, 7 February 2025
Ripple XRP price prediction: Third-party price target
Discover the ripple (XRP) price predictions for 2025 and beyond, with analyst price targets and CFDs trading strategies on Capital.com
15:29, 6 February 2025
Apple (AAPL) stock price forecast: third-party price target
We looked at the forecasts for Apple stock in 10 years to see where the price would likely be at that point and the challenges the company could face. Read more.
11:22, 6 February 2025
FARTCOIN price prediction: Third-party price target
Read our FARTCOIN price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:18, 29 January 2025
MELANIA coin ($MELANIA) price prediction: Third party price target
Read our MELANIA crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts.
11:33, 22 January 2025
TRUMP coin ($TRUMP) price prediction: third-party price target
Read our TRUMP crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:52, 22 January 2025
Ethereum price prediction: Third party data round up
What is the outlook for ETH as a long-term investment?
16:37, 7 January 2025People also watch
Still looking for a broker you can trust?
Join the 690,000+ traders worldwide that chose to trade with Capital.com